Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Liam Taylor, CEO, Axol Bioscience
    18 February 2026

    Axol Bioscience acquires ophthalmology business from Newcells Biotech

    ·  Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models ·  Strengthens position as the leading independent provider of physiologically-relevant in vitro retinal models for ophthalmology drug discovery and safety...

    leadXpro scientists with the eProtein Discovery System
    17 February 2026

    Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins

    Partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targetsTo de-risk and shorten path to critical structural and biophysical insights that inform structure-based drug designCambridge, UK, Boston MA, USA and Villigen, Switzerland, 17 February 20...

    successfully raisKluraLabs raises £8 million in funding to accelerate the rollout of its pioneering technology across global retail supply chains.
    17 February 2026

    KluraLabs secures £8 Million to scale packaging innovation and reduce food waste globally

    KluraLabs, The EpiCentre-based materials science company transforming food packaging in Haverhill, has successfully raised £8 million in funding to accelerate the rollout of its pioneering technology across global retail supply chains. ...

    keypassword, microsoft edge
    15 February 2026

    Finally, a fix for password chaos

    How many hours have you and your team lost to forgotten passwords, reset emails, or lockouts?Probably more than you’d like to admit.Microsoft Edge has introduced this simple but very welcome improvement…Click here to learn more: https://breathetechnology.com/blog/at-last-sync-passkeys-a...

    Alison Taylor, CEO at Conscious Communications and Jason Longhurst, UK Head of Sustainable Investment and Partnerships at Prologis
    16 February 2026

    Prologis appoints Cambridge-based B Corp Conscious Communications to support local engagement and communications

    Global property investor, owner and developer, Prologis, has appointed Conscious Communications, the Cambridge-based B Corp certified communications agency, to support its local communications and stakeholder engagement activity around its investment in and development of the Cambridge ...

    The EpiCentre’s business support helps solopreneurs turn their ideas into a viable business.
    16 February 2026

    Your idea has momentum - what do you need to get to the next stage?

    The EpiCentre’s business support helps solopreneurs turn their ideas into a viable business. ...

    Microsoft 11, Ask Copilot
    12 February 2026

    Ask Copilot" is coming to your Taskbar (but only if you want it to)

    Have you ever wished your computer just understood what you were trying to do, instead of making you dig through menus and search results to get there?Microsoft’s working on it.In the latest Windows 11 preview, there’s a new feature being tested called Ask Copilot. It’s taking centre st...

    MarkArgent.jpg
    10 February 2026

    Mark Argent joins Salus Wellness

    We are very pleased to announce that Mark Argent has joined Salus Wellness Clinics. ...

    Dr Lara Zibners, Co-founder and Chairman (left), and Thang Vo-Ta, Co-founder and CEO (right), Calla Lily Clinical Care
    10 February 2026

    Calla Lily Clinical Care and Merck announce strategic collaboration to advance intravaginal drug delivery platform

    Enhancing patient treatment experience and care with a new self-administered solution for vaginal therapeuticsVersatile platform technology developed from a safe, award-winning, FDA-cleared medical deviceStrategic collaboration supporting the continued development of a novel intravagina...

    Carterra Vega™ High-Throughput Surface Plasmon Resonance (HT-SPR) instrument
    10 February 2026

    Carterra launches industry’s first 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization

    · Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discovery· Enables primary screening with high-resolution binding· First order and shipment slated for Q1 will be to a KOL at a top 10 pharma ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 33
    • Page 34
    • Current page 35
    • Page 36
    • Page 37
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS